Artesunate/Piperaquine

青蒿琥酯/磷酸哌喹

Report date: 2022/07/04 19:38:02

Base Information

Drug NameArtesunate/Piperaquine
Drug Alias NameArtesunate+Piperaquine磷酸哌喹+青蒿琥酯磷酸哌喹/青蒿琥酯Piperaquine+Artesunate青蒿琥酯+磷酸哌喹 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytochrome P450 3A4 inhibitorsSarcoplasmic/endoplasmic reticulum calcium ATPase 1 inhibitorsSarcoplasmic/endoplasmic reticulum calcium ATPase 2 inhibitors
TargetsCytochrome P450 3A4Sarcoplasmic/endoplasmic reticulum calcium ATPase 1Sarcoplasmic/endoplasmic reticulum calcium ATPase 2
Therapy Area/IndicationsMalaria, Falciparum
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRwandaTanzaniaNigeria +[6] 
CombinationsYes ArtesunatePiperaquine Phosphate
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Oxford
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Oxford
Inactive CompaniesN/A
Active IndicationsMalaria, Falciparum
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A